Australia - angielski - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - hyoscine hydrobromide, quantity: 400 microgram/ml - injection, solution - excipient ingredients: water for injections - hyoscine injection bp is indicated as a pre-operative medication to produce sedation and amnesia. it is also used pre-operatively to inhibit salivation and excessive secretions of the respiratory tract. hyoscine hydrobromide is also indicated for the treatment of selected cases of nausea and vomiting resulting from motion sickness, although oral or transdermal administration is more frequently used for this indication.

Malta - angielski - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - hyoscine hydrobromide - solution for injection - hyoscine hydrobromide 0.04 % (w/v) - antiemetics and antinauseants

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - hyoscine hydrobromide - solution for injection - 400 microgram(s)/millilitre - other antiemetics

Australia - angielski - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - hyoscine butylbromide, quantity: 20 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - hyoscine butylbromide -

Kanada - angielski - Health Canada

omega laboratories limited - hyoscine butylbromide - solution - 20mg - hyoscine butylbromide 20mg - antimuscarinics antispasmodics

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - hyoscine hydrobromide trihydrate 0.4 mg/ml - solution for injection - 0.4 mg/ml - active: hyoscine hydrobromide trihydrate 0.4 mg/ml

Australia - angielski - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - spasm of the gastrointestinal tract.

Malezja - angielski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - hyoscine butylbromide -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - hyoscine butylbromide, quantity: 20 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.